AAAAAA

   
Results: 1-19 |
Results: 19
INFLUENCE OF CLINICAL-DIAGNOSIS IN THE POPULATION PHARMACOKINETICS OFAMIKACIN IN INTENSIVE-CARE UNIT PATIENTS
Authors: ROMANO S DEGATTA MDF CALVO V MENDEZ E DOMINGUEZGIL A LANAO JM
Citation: S. Romano et al., INFLUENCE OF CLINICAL-DIAGNOSIS IN THE POPULATION PHARMACOKINETICS OFAMIKACIN IN INTENSIVE-CARE UNIT PATIENTS, Clinical drug investigation, 15(5), 1998, pp. 435-444
INFLUENCE OF VERAPAMIL AND DIGOXIN ON THE IN-VITRO BINDING OF DOXORUBICIN TO THE RAT-HEART
Authors: ALVAREZCEDRON L LOPEZ FG LANAO JM
Citation: L. Alvarezcedron et al., INFLUENCE OF VERAPAMIL AND DIGOXIN ON THE IN-VITRO BINDING OF DOXORUBICIN TO THE RAT-HEART, Biological & pharmaceutical bulletin, 21(8), 1998, pp. 839-843
IN-VITRO CHARACTERIZATION OF CIPROFLOXACIN DISTRIBUTION IN RAT LUNG
Authors: REINOSO RF NAVARRO AS LANAO JM
Citation: Rf. Reinoso et al., IN-VITRO CHARACTERIZATION OF CIPROFLOXACIN DISTRIBUTION IN RAT LUNG, Methods and findings in experimental and clinical pharmacology, 20(5), 1998, pp. 369-375
IN-VITRO STUDY OF THE BINDING OF DOXORUBICIN TO HEART
Authors: ALVAREZCEDRON L LOPEZ FG LANAO JM
Citation: L. Alvarezcedron et al., IN-VITRO STUDY OF THE BINDING OF DOXORUBICIN TO HEART, European journal of drug metabolism and pharmacokinetics, 23(2), 1998, pp. 132-136
PHARMACOKINETIC PARAMETERS OF NETILMICIN AND PROTECTIVE EFFECT OF PIPERACILLIN REGARDING NEPHROTOXICITY CAUSED BY NETILMICIN
Authors: NAVARRO MS CASTANEDA AZ LOPEZ FG NAVARRO AS AREVALO M LANAO JM
Citation: Ms. Navarro et al., PHARMACOKINETIC PARAMETERS OF NETILMICIN AND PROTECTIVE EFFECT OF PIPERACILLIN REGARDING NEPHROTOXICITY CAUSED BY NETILMICIN, European journal of drug metabolism and pharmacokinetics, 23(2), 1998, pp. 143-147
INFLUENCE OF DIAGNOSTIC AND TREATMENT FACTORS IN THE POPULATION PHARMACOKINETICS OF GENTAMICIN
Authors: ROMANO S GONZALEZ P TEJADA P ANTON J AGUADO JM LANAO JM
Citation: S. Romano et al., INFLUENCE OF DIAGNOSTIC AND TREATMENT FACTORS IN THE POPULATION PHARMACOKINETICS OF GENTAMICIN, Journal of clinical pharmacy and therapeutics, 23(2), 1998, pp. 141-148
A COMPARATIVE-STUDY OF OFLOXACIN AND CIPROFLOXACIN ERYTHROCYTE DISTRIBUTION
Authors: COLINO CI TURINO AG NAVARRO AS LANAO JM
Citation: Ci. Colino et al., A COMPARATIVE-STUDY OF OFLOXACIN AND CIPROFLOXACIN ERYTHROCYTE DISTRIBUTION, Biopharmaceutics & drug disposition, 19(2), 1998, pp. 71-77
STUDY ON PHARMACOKINETICS AND NEPHROTOXICITY OF NETILMICIN IN RABBITSUSING A NEW DOSAGE REGIMEN
Authors: SANTOS M AREVALO M COLINO CI LOPEZ FG NAVARRO AS DOMINGUEZGIL A LANAO JM
Citation: M. Santos et al., STUDY ON PHARMACOKINETICS AND NEPHROTOXICITY OF NETILMICIN IN RABBITSUSING A NEW DOSAGE REGIMEN, Methods and findings in experimental and clinical pharmacology, 19(1), 1997, pp. 53-59
POPULATION PHARMACOKINETICS OF CAFFEINE IN PREMATURE NEONATES
Authors: FALCAO AC DEGATTA MMF IRIBARNEGARAY MFD BUELGA DS GARCIA MJ DOMINGUEZGIL A LANAO JM
Citation: Ac. Falcao et al., POPULATION PHARMACOKINETICS OF CAFFEINE IN PREMATURE NEONATES, European Journal of Clinical Pharmacology, 52(3), 1997, pp. 211-217
DETERMINATION OF PIPERACILLIN IN BIOLOGICAL SAMPLES BY HPLC
Authors: ZARZUELO A LOPEZ FG SANTOS M LANAO JM
Citation: A. Zarzuelo et al., DETERMINATION OF PIPERACILLIN IN BIOLOGICAL SAMPLES BY HPLC, Journal of liquid chromatography & related technologies, 19(4), 1996, pp. 601-610
BAYESIAN FORECASTING IN PEDIATRIC POPULATIONS
Authors: DEGATTA MMF GARCIA MJ LANAO JM DOMINGUEZGIL A
Citation: Mmf. Degatta et al., BAYESIAN FORECASTING IN PEDIATRIC POPULATIONS, Clinical pharmacokinetics, 31(5), 1996, pp. 325-330
PHARMACOKINETICS OF AMIKACIN IN INTENSIVE-CARE UNIT PATIENTS
Authors: DEGATTA MMF MENDEZ ME ROMANO S CALVO MV DOMINGUEZGIL A LANAO JM
Citation: Mmf. Degatta et al., PHARMACOKINETICS OF AMIKACIN IN INTENSIVE-CARE UNIT PATIENTS, Journal of clinical pharmacy and therapeutics, 21(6), 1996, pp. 417-421
INFLUENCE OF PHARMACOKINETIC MODEL ON VANCOMYCIN PEAK CONCENTRATION TARGETS
Authors: DEGATTA MMF FRUNS I CALVO MV LANAO JM DOMINGUEZGIL A
Citation: Mmf. Degatta et al., INFLUENCE OF PHARMACOKINETIC MODEL ON VANCOMYCIN PEAK CONCENTRATION TARGETS, Therapeutic drug monitoring, 18(2), 1996, pp. 145-148
EFFECT OF UREA ON THE IN-VITRO BINDING OF NETILMICIN TO RENAL TISSUE IN RATS
Authors: GARCIA E LANAO JM LOPEZ FG SANTOS M COLINO CI DOMINGUEZGIL A
Citation: E. Garcia et al., EFFECT OF UREA ON THE IN-VITRO BINDING OF NETILMICIN TO RENAL TISSUE IN RATS, Clinical drug investigation, 9(1), 1995, pp. 22-29
DETERMINATION OF NETILMICIN IN PLASMA BY HPLC
Authors: SANTOS M GARCIA E LOPEZ FG LANAO JM DOMINGUEZGIL A
Citation: M. Santos et al., DETERMINATION OF NETILMICIN IN PLASMA BY HPLC, Journal of pharmaceutical and biomedical analysis, 13(8), 1995, pp. 1059-1062
CALCULATION OF PARTIAL COMPONENTS OF BIOAVAILABILITY IN SLOW-RELEASE FORMULATIONS USING MODEL-INDEPENDENT METHODS
Authors: LANAO JM VICENTE MT SAYALERO ML
Citation: Jm. Lanao et al., CALCULATION OF PARTIAL COMPONENTS OF BIOAVAILABILITY IN SLOW-RELEASE FORMULATIONS USING MODEL-INDEPENDENT METHODS, International journal of pharmaceutics, 117(1), 1995, pp. 113-118
STUDY OF ZINC TRANSPORT DURING HEMOFILTRATION
Authors: DELEON B GONZALEZ CM LANAO JM GASCON A TABERNERO JM
Citation: B. Deleon et al., STUDY OF ZINC TRANSPORT DURING HEMOFILTRATION, Kidney international, 46(2), 1994, pp. 577-577
VANCOMYCIN PHARMACOKINETICS AND DOSAGE REQUIREMENTS IN HEMATOLOGIC MALIGNANCIES
Authors: DEGATTA MDF FRUNS I HERNANDEZ JM CABALLERO D MIGUEL JFS LANAO JM HURLE ADG
Citation: Mdf. Degatta et al., VANCOMYCIN PHARMACOKINETICS AND DOSAGE REQUIREMENTS IN HEMATOLOGIC MALIGNANCIES, Clinical pharmacy, 12(7), 1993, pp. 515-520
A COMPARATIVE-STUDY OF THE POPULATION PHARMACOKINETICS OF GENTAMICIN AND AMIKACIN IN NEWBORN PATIENTS
Authors: IZQUIERDO M LANAO JM CERVERO L JIMENEZ NV DOMINGUEZGIL A
Citation: M. Izquierdo et al., A COMPARATIVE-STUDY OF THE POPULATION PHARMACOKINETICS OF GENTAMICIN AND AMIKACIN IN NEWBORN PATIENTS, Journal of clinical pharmacy and therapeutics, 18(6), 1993, pp. 411-413
Risultati: 1-19 |